Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
about
Recent developments in the management of invasive fungal infections in patients with oncohematological diseasesThe effects of orally administered Beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-studyQuantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting.Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastomaLevels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida speciesClinical and laboratory update on blastomycosis.Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological testsMolecular and nonmolecular diagnostic methods for invasive fungal infections.Fungal diagnostics in pneumoniaCanadian clinical practice guidelines for invasive candidiasis in adults.Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients.β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot studyβ-D-Glucan Assay in Diagnosis and Monitoring the Systemic Candidiasis in a Rat Model.The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Mycobacterium avium infection improved by microbial substitution of fungal infectionPersistence of a positive (1,3)-beta-D-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipientsUtility of measuring (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infectionSerum 1,3-βD-Glucan assay in the diagnosis of invasive fungal disease in neonates.Laboratory diagnosis of mucormycosis: current status and future perspectives.Platelet parameters and (1, 3)-β-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants.Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based studyRapid microbial sample preparation from blood using a novel concentration device.Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.The Screening Performance of Serum 1,3-Beta-D-Glucan in Patients with Invasive Fungal Diseases: A Meta-Analysis of Prospective Cohort StudiesImproved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens.Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index.Serological response and diagnostic value of recombinant candida cell wall protein enolase, phosphoglycerate kinase, and β-glucosidase.Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.Serum Aspergillus galactomannan for the management of disseminated histoplasmosis in AIDS.Fungal infections: their diagnosis and treatment in transplant recipients.Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology.Measuring (1,3)-β-D-glucan in tracheal aspirate, bronchoalveolar lavage fluid, and serum for detection of suspected Candida pneumonia in immunocompromised and critically ill patients: a prospective observational study.Plasmonic gold nanoparticles for detection of fungi and human cutaneous fungal infections.Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis.Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.Improved detection of circulating Aspergillus antigen by use of a modified pretreatment procedure
P2860
Q28077381-5A44B66E-04B4-4827-A53D-4F4C1F714DB8Q28543440-2AD88D69-A435-414B-8638-6742DCD1E15FQ31114184-6F2A2B40-8655-435B-A46D-37CCA253A3A7Q33296907-635288E3-B345-4D72-A527-BB9AC2D2E055Q33408675-397E1EFB-47AC-43B7-BCC7-AEAF15D3B9FFQ33711043-49BA6F94-B048-4ED4-B6E4-6588BCFB8DD0Q33825592-C08B657F-52DB-47E5-AB85-4FDE8F25C16EQ33900089-E6A51CFF-67C7-47BD-9039-7F375A24D942Q33918012-3F5C0E22-6358-4447-931B-49C407D856E4Q34057660-AD2207D5-1BF1-4DF2-B99C-75977FCC9E7AQ34153565-EBF9D2DD-E893-4B2F-8E37-C0E7DEBD9F28Q34237335-25199B4A-7601-414E-BCEA-6604F68B95C3Q34260841-9DA9030A-FF45-4538-A259-10F4DF6667CDQ34374081-3A1AC22C-C4C7-4ED2-8CE9-48812A095185Q34443501-7950A2DE-3E40-4BC5-9E73-F36CCE7BE6C5Q34489333-9F1A6D26-FE66-43A9-AD03-D48066DD224DQ34505582-F9DB6B9F-1E98-4570-91A5-1BD28825934DQ34523238-DEBAD9FC-D32A-47B6-B797-98AAE17E85DDQ34739041-3FE1B184-DB42-4645-AD35-2045CCFFF27EQ34916859-4093B266-CAB3-43D8-A21B-03567BF5617EQ35096947-A246BCEA-3292-48C1-8C1F-51785D8C8BBDQ35193540-20AF85BC-0F61-44AB-AE5E-1163D440E68EQ35394057-2B4B1A54-D906-4B8F-934D-19C869946457Q35530416-A222A137-1A69-4359-8060-09DE51FE08E0Q35559894-09272767-8152-442C-A94B-C6117F54F354Q35668212-6103AEB7-43FC-490E-ABEE-A6E819F6D6EEQ35683091-9523BBF0-C0FE-4701-9674-508193874263Q35845437-701984A6-66EB-478F-A9BA-E4B4D7652426Q35908296-87FD8790-FF72-483E-A6A3-61199B04F5A3Q36044059-49EFD31A-5191-4D56-9FC9-DCD6688E4AC7Q36094242-A8C2769F-01B8-4551-BB38-D5B0CA343929Q36149648-27634070-3CC8-4B12-BABC-3CF2342146F1Q36206568-41FED628-0FC2-46CF-8224-E1283B26064EQ36286567-458FD2AC-9180-4754-BD0A-358DA61E112BQ36340864-0757BD14-23F1-4267-90AF-74813BA87537Q36390252-14DE62E7-42F5-46F6-8EDE-4EF8B8DC0B34Q36396166-05D994EC-4650-4505-A11A-7D1609F73198Q36482821-801C2DB4-528F-429A-A159-0F8C52D0EE80Q36497847-CFEA23BE-02C5-4692-A1AE-BD97450ECAC2Q36539727-F2E2FA41-2954-49C7-9F9B-9CBECB009A83
P2860
Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
@en
type
label
Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
@en
prefLabel
Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
@en
P2093
P2860
P1476
Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
@en
P2093
Catherine A P Bowles
Gail L Woods
Howard W Sant
Jerry W Pickering
William L Roberts
P2860
P304
P356
10.1128/JCM.43.12.5957-5962.2005
P407
P577
2005-12-01T00:00:00Z